Literature DB >> 25586022

In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria.

Kwang-sun Kim1, Taeyeon Kim2, Jae-Gu Pan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25586022     DOI： 10.1038/ja.2014.164

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  19 in total

1.  In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.

Authors:  D W Wareham; D C Bean
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Ciclopirox protects mitochondria from hydrogen peroxide toxicity.

Authors:  Sun J Lee; Youngnam Jin; Hye Young Yoon; Byung-Ok Choi; Hyoung Chun Kim; Yu-Kyoung Oh; Hee-Sun Kim; Won-Ki Kim
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  [The use of colimycin ear drops].

Authors:  R Ohzawa
Journal:  Jibiinkoka       Date:  1965-06

4.  [Clinical use of colimycin F otic solution].

Authors:  S Nakajima
Journal:  Jibiinkoka       Date:  1965-07

5.  Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.

Authors:  Bing Zhai; Henry Zhou; Liangpeng Yang; Jun Zhang; Kathy Jung; Chou-Zen Giam; Xin Xiang; Xiaorong Lin
Journal:  J Antimicrob Chemother       Date:  2010-02-18       Impact factor: 5.790

6.  In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.

Authors:  Xiaomeng Dong; Fengzhe Chen; Yajun Zhang; Haihong Liu; Yongjuan Liu; Lixian Ma
Journal:  J Antibiot (Tokyo)       Date:  2014-08-06       Impact factor: 2.649

7.  Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster.

Authors:  G Stevenson; B Neal; D Liu; M Hobbs; N H Packer; M Batley; J W Redmond; L Lindquist; P Reeves
Journal:  J Bacteriol       Date:  1994-07       Impact factor: 3.490

8.  Drugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005-2010.

Authors:  Benedikt Huttner; Makoto Jones; Michael A Rubin; Melinda M Neuhauser; Adi Gundlapalli; Matthew Samore
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

9.  Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing.

Authors:  Sae Hee Ko; Allison Nauta; Shane D Morrison; Hongyan Zhou; Andrew Zimmermann; Geoffrey C Gurtner; Sheng Ding; Michael T Longaker
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

10.  Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.

Authors:  Kimberly M Carlson-Banning; Andrew Chou; Zhen Liu; Richard J Hamill; Yongcheng Song; Lynn Zechiedrich
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240
View more
  7 in total

1.  Polymyxin B-Induced Diffuse Cutaneous Hyperpigmentation.

Authors:  Sandeep Lahiry; Shouvik Choudhury; Ayan Mukherjee; Prajesh Kiran Bhunya; Moumita Bala
Journal:  J Clin Diagn Res       Date:  2017-02-01

2.  Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.

Authors:  Joon-Hui Chung; Abhayprasad Bhat; Chang-Jin Kim; Dongeun Yong; Choong-Min Ryu
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

3.  Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli.

Authors:  Zachary C Conley; Kimberly M Carlson-Banning; Ashley G Carter; Alejandro de la Cova; Yongcheng Song; Lynn Zechiedrich
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

4.  Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro.

Authors:  Lan Yu; Jisheng Zhang; Yanjun Fu; Yongxin Zhao; Yong Wang; Jing Zhao; Yuhang Guo; Chunjiang Li; Xiaoli Zhang
Journal:  Front Cell Infect Microbiol       Date:  2019-12-10       Impact factor: 5.293

5.  Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters.

Authors:  Miaomiao Xie; Kaichao Chen; Edward Wai-Chi Chan; Sheng Chen
Journal:  Microbiol Spectr       Date:  2022-04-25

6.  Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria.

Authors:  Hyejin Cho; Kwang-Sun Kim
Journal:  Pharmaceutics       Date:  2022-03-01       Impact factor: 6.321

7.  Polymyxin B-induced rhabdomyolysis: A case report.

Authors:  Ming Ni; Xiangdong Meng; Limin Wang; Yanan Zhao; Min Yu; Sheng Shi
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.